| Literature DB >> 24859449 |
Juan Liu1, Chaofeng Han2, Bin Xie3, Yue Wu4, Shuxun Liu5, Kun Chen6, Meng Xia6, Yuan Zhang7, Lijun Song5, Zhiqing Li6, Ting Zhang6, Feng Ma6, Qingqing Wang6, Jianli Wang6, Kejing Deng8, Yuan Zhuang8, Xiaohui Wu8, Yizhi Yu5, Tian Xu8, Xuetao Cao9.
Abstract
Excessive activation of dendritic cells (DCs) leads to the development of autoimmune and inflammatory diseases, which has prompted a search for regulators of DC activation. Here we report that Rhbdd3, a member of the rhomboid family of proteases, suppressed the activation of DCs and production of interleukin 6 (IL-6) triggered by Toll-like receptors (TLRs). Rhbdd3-deficient mice spontaneously developed autoimmune diseases characterized by an increased abundance of the TH17 subset of helper T cells and decreased number of regulatory T cells due to the increase in IL-6 from DCs. Rhbdd3 directly bound to Lys27 (K27)-linked polyubiquitin chains on Lys302 of the modulator NEMO (IKKγ) via the ubiquitin-binding-association (UBA) domain in endosomes. Rhbdd3 further recruited the deubiquitinase A20 via K27-linked polyubiquitin chains on Lys268 to inhibit K63-linked polyubiquitination of NEMO and thus suppressed activation of the transcription factor NF-κB in DCs. Our data identify Rhbdd3 as a critical regulator of DC activation and indicate K27-linked polyubiquitination is a potent ubiquitin-linked pattern involved in the control of autoimmunity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24859449 DOI: 10.1038/ni.2898
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606